Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.
A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...
There's growing evidence to suggest that GLP-1 drugs, which include semaglutide, may be useful for treating alcohol use disorder.
But when averaging the number of drinks only on the days alcohol was consumed, the reduction was greater in the Ozempic group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback